MMF, S., CG, S., KJ, H., RC, R., D, G., K, M., . . . MM, v. d. H. (2025). Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study. PLoS medicine, 22(4), e1004574. https://doi.org/10.1371/journal.pmed.1004574
Chicago Style (17th ed.) CitationMMF, Schuurbiers, et al. "Recurrence Prediction Using Circulating Tumor DNA in Patients with Early-stage Non-small Cell Lung Cancer After Treatment with Curative Intent: A Retrospective Validation Study." PLoS Medicine 22, no. 4 (2025): e1004574. https://doi.org/10.1371/journal.pmed.1004574.
MLA (9th ed.) CitationMMF, Schuurbiers, et al. "Recurrence Prediction Using Circulating Tumor DNA in Patients with Early-stage Non-small Cell Lung Cancer After Treatment with Curative Intent: A Retrospective Validation Study." PLoS Medicine, vol. 22, no. 4, 2025, p. e1004574, https://doi.org/10.1371/journal.pmed.1004574.